-
Mashup Score: 55
60 per cent of patients given DaraCyBorD had no sign of AL amyloidosis 20 months later – its NHS approval follows a year-long campaign by Myeloma UK, clinicians and patients
Source: inews.co.ukCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 55
60 per cent of patients given DaraCyBorD had no sign of AL amyloidosis 20 months later – its NHS approval follows a year-long campaign by Myeloma UK, clinicians and patients
Source: inews.co.ukCategories: General Medicine News, Hem/OncsTweet-
Victory for patients with incurable disease after NHS treatment U-turn https://t.co/HKdOmsUe0d Such great news and top work from @MyelomaUK and all who worked so hard to make this happen
-
-
Mashup Score: 4Outcomes of patients with light chain (AL) amyloidosis after failure of daratumumab‐based therapy - 6 month(s) ago
An official journal of the British Society for Haematology, the British Journal of Haematology offers high visibility for clinical, basic and translational research.
Source: onlinelibrary.wiley.comCategories: General Medicine News, Hem/OncsTweet-
RT @thanosdimop: Another paper on AL amyloidosis from our group! https://t.co/dpvaLaTnZV
-
-
Mashup Score: 1WEBINAR: Update and Debate in Myeloma - 6 month(s) ago
Join the limbic for an update on the key developments in clinical practice for myeloma in the UK over the last 12 months, along with a debate on whether CAR T-cell therapy will be usurped by bispecific therapy in the treatment of myeloma. Hosted by Prof. Graham Jackson. Consultant Haematologist at Newcastle Hospitals Trust, Newcastle upon Tyne […]
Source: thelimbic.comCategories: General Medicine News, Hem/OncsTweet-
RT @thelimbichaemUK: REGISTER: https://t.co/9DiIy5t4cL Join us for a discussion on the key developments in myeloma in the UK & whether CAR…
-
-
Mashup Score: 3PODCAST: Supportive care in haemato-oncology: Treatment toxicities - 7 month(s) ago
Supportive care in haemato-oncology In this four-part educational series on supportive care in haemato-oncology, our team of expert clinicians will guide you through what supportive care means in blood cancers, managing infection, dealing with treatment toxicities, and psychosocial support and palliative care. We will discuss whether clinicians and patients are always on the same page […]
Source: thelimbic.comCategories: Hem/Oncs, Latest HeadlinesTweet-
RT @thelimbichaemUK: LISTEN: https://t.co/o46bNX0maY In this episode, @profBigG and @profghjackson discuss managing toxicities associated w…
-
-
Mashup Score: 3The 67 best places to eat this summer in the UK - 8 month(s) ago
From Scottish fish and chips to a perfect Devon pub, top chefs recommend their favourite cafes, restaurants and inns in the UK for lunch or dinner, or just to while away a lazy sunny afternoon
Source: www.theguardian.comCategories: Hem/Oncs, Latest HeadlinesTweet-
RT @LakeRoadKitchen: Lovely mention in @ObsFood this month. https://t.co/VAkQ5RVcPQ
-
-
Mashup Score: 52023 International Myeloma Society Annual Meeting: Abstracts - 1 year(s) ago
The Scientific Program Committee invites you to submit an abstract for the 20th International Myeloma Society Annual Meeting, taking place September 27-30, 2023 in Athens, Greece. Abstract Categories for IMS Annual 2023: Treatment of Newly Diagnosed Myeloma- Transplant Eligible Treatment of Newly Diagnosed Myeloma- Non-Transplant Eligible Treatment of Relapsed/Refractory…
Source: events.jspargo.comCategories: Hem/Oncs, Latest HeadlinesTweet-
RT @Myeloma_Society: The abstract portal for #IMS2023 is open until May 30! Learn more and submit here: https://t.co/RE6KvycgG1 https://t.c…
-
-
Mashup Score: 1
Oral and Poster Abstracts Oral 652. Multiple Myeloma and Plasma Cell Dyscrasias: Clinical and Epidemiological: Precursor States: MGUS and Smoldering Myeloma adult, Research, Clinical Research, real-world evidence, Human, Study Population Elias Eythorsson, MD, PhD1*, Sæmundur Rögnvaldsson, MD1,2*, Sigrún Thorsteinsdóttir, MD, PhD3,4, Elin Ruth Reed3*,…
Source: ash.confex.comCategories: Hem/Oncs, Latest HeadlinesTweet-
RT @sykristinsson: #107 https://t.co/ZGqXHCm3Tv @eliaseythorsson Yes, I shamelessly picked one of my own abstracts :) Predicting the need…
-
-
Mashup Score: 7Paper: Hypercalcemia in Individuals with Monoclonal Gammopathy of Undetermined Significance: Results from the Istopmm Study - 1 year(s) ago
Oral and Poster Abstracts 652. Multiple Myeloma and Plasma Cell Dyscrasias: Clinical and Epidemiological: Poster III Research, adult, Clinical Practice (Health Services and Quality), elderly, Plasma Cell Disorders, Diseases, Lymphoid Malignancies, Study Population, Human Ástrún Helga Jónsdóttir1*, Sæmundur Rögnvaldsson, MD1,2*, Helga Ágústa…
Source: ash.confex.comCategories: Hem/Oncs, Latest HeadlinesTweet-
RT @sykristinsson: https://t.co/8jfMTQluaf The “C“ in CRAB does not walk alone! Checking s-calcium in 2546 individuals with MGUS: 7.5% h…
-
-
Mashup Score: 7mSMART - 1 year(s) ago
The Risk Adapted Approach to Management of Multiple Myeloma and Related DisordersOur mission is to present the state of the art approach to management of these plasma cells disorders including Myeloma, Amyloidosis, and Waldenstrom’s Macroglobulinemia. Views expressed here are opinions of a group of experts, based on best available evidence.
Source: mSMARTCategories: Hem/Oncs, Latest HeadlinesTweet-
RT @VincentRK: Ahead of #ASH22 here is the current risk stratification I follow for myeloma. https://t.co/9SVglZ1DrM #ASH22 @myelomaMD ht…
-
Victory for patients with incurable disease after NHS treatment U-turn https://t.co/HKdOmsUe0d Such great news and top work from @MyelomaUK and all who worked so hard to make this happen